LSm4激活剂

The indirect activators of LSm4 are primarily focused on modulating various aspects of RNA processing and splicing. Compounds like spliceosome inhibitors (including Pladienolide) and U1 snRNP inhibitors target specific components of the splicing machinery, altering the splicing process in which LSm4 is involved. By modulating spliceosome activity, these compounds could indirectly influence the role of LSm4 in RNA processing.

Actinomycin D and DRB, impact the synthesis of RNA, thereby affecting the overall RNA processing landscape, including the functions of LSm4. Similarly, RNase inhibitors, by preserving RNA integrity, could indirectly influence the RNA processing events where LSm4 plays a role.

Leptomycin B, by inhibiting nuclear export, can affect the distribution and processing of RNA within the cell, impacting LSm4's function. Compounds like Amiloride, which inhibit RNA helicases, could also influence RNA processing pathways involving LSm4. SMN complex modulators represent broader categories that can influence cellular signaling pathways and the assembly of spliceosomal components, respectively. These broader impacts on cellular pathways could indirectly modulate the function of LSm4 in RNA processing.